Annual Current Liabilities
$19.05 M
+$3.46 M+22.22%
31 December 2023
Summary:
NRx Pharmaceuticals annual total current liabilities is currently $19.05 million, with the most recent change of +$3.46 million (+22.22%) on 31 December 2023. During the last 3 years, it has fallen by -$27.12 million (-58.74%). NRXPW annual current liabilities is now -58.74% below its all-time high of $46.16 million, reached on 31 December 2020.NRXPW Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$20.30 M
-$3.36 M-14.19%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly total current liabilities is currently $20.30 million, with the most recent change of -$3.36 million (-14.19%) on 30 September 2024. Over the past year, it has increased by +$972.00 thousand (+5.03%). NRXPW quarterly current liabilities is now -44.05% below its all-time high of $36.28 million, reached on 30 September 2021.NRXPW Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.2% | +5.0% |
| 3 y3 years | -58.7% | -44.0% |
| 5 y5 years | - | +3063.1% |
NRXPW Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -58.7% | +59.8% | -44.0% | +186.7% |
| 5 y | 5 years | -58.7% | +2960.2% | -44.0% | >+9999.0% |
| alltime | all time | -58.7% | +2960.2% | -44.0% | >+9999.0% |
NRx Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.30 M(-14.2%) |
| June 2024 | - | $23.66 M(+25.4%) |
| Mar 2024 | - | $18.86 M(-1.0%) |
| Dec 2023 | $19.05 M(+22.2%) | $19.05 M(-1.4%) |
| Sept 2023 | - | $19.33 M(+172.9%) |
| Dec 2022 | $15.59 M(+30.7%) | - |
| June 2022 | - | $7.08 M(-40.6%) |
| Mar 2022 | - | $11.91 M(-0.1%) |
| Dec 2021 | $11.92 M | $11.92 M(-67.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $36.28 M(+2.3%) |
| June 2021 | - | $35.47 M(>+9900.0%) |
| Dec 2020 | $46.16 M(+7316.6%) | $2419.40(>+9900.0%) |
| Sept 2020 | - | $2.07(-100.0%) |
| June 2020 | - | $297.24 K(-6.1%) |
| Mar 2020 | - | $316.38 K(-49.2%) |
| Dec 2019 | $622.44 K | $622.44 K(-3.0%) |
| Sept 2019 | - | $641.75 K(+23.1%) |
| June 2019 | - | $521.15 K(+5.4%) |
| Mar 2019 | - | $494.39 K |
FAQ
- What is NRx Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual current liabilities year-on-year change?
- What is NRx Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly current liabilities year-on-year change?
What is NRx Pharmaceuticals annual total current liabilities?
The current annual current liabilities of NRXPW is $19.05 M
What is the all time high annual current liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual total current liabilities is $46.16 M
What is NRx Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, NRXPW annual total current liabilities has changed by +$3.46 M (+22.22%)
What is NRx Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of NRXPW is $20.30 M
What is the all time high quarterly current liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly total current liabilities is $36.28 M
What is NRx Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, NRXPW quarterly total current liabilities has changed by +$972.00 K (+5.03%)